FDA accelerated approval benefits glioblastoma

被引：21

作者：

Cloughesy, Timothy ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA

来源：

LANCET ONCOLOGY | 2010年 / 11卷 / 12期

关键词：

D O I：

10.1016/S1470-2045(10)70269-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1120 / 1120

页数：1

共 5 条

[1] FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma Multiforme [J].

Cohen, Martin H. ;

Shen, Yuan Li ;

Keegan, Patricia ;

Pazdur, Richard .

ONCOLOGIST, 2009, 14 (11) :1131-1138

[2] Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma [J].

Friedman, Henry S. ;

Prados, Michael D. ;

Wen, Patrick Y. ;

Mikkelsen, Tom ;

Schiff, David ;

Abrey, Lauren E. ;

Yung, W. K. Alfred ;

Paleologos, Nina ;

Nicholas, Martin K. ;

Jensen, Randy ;

Vredenburgh, James ;

Huang, Jane ;

Zheng, Maoxia ;

Cloughesy, Timothy .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) :4733-4740

[3] Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group [J].

Wen, Patrick Y. ;

Macdonald, David R. ;

Reardon, David A. ;

Cloughesy, Timothy F. ;

Sorensen, A. Gregory ;

Galanis, Evanthia ;

DeGroot, John ;

Wick, Wolfgang ;

Gilbert, Mark R. ;

Lassman, Andrew B. ;

Tsien, Christina ;

Mikkelsen, Tom ;

Wong, Eric T. ;

Chamberlain, Marc C. ;

Stupp, Roger ;

Lamborn, Kathleen R. ;

Vogelbaum, Michael A. ;

van den Bent, Martin J. ;

Chang, Susan M. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (11) :1963-1972

[4] Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse [J].

Yung, WKA ;

Prados, MD ;

Yaya-Tur, R ;

Rosenfeld, SS ;

Brada, M ;

Friedman, HS ;

Albright, R ;

Olson, J ;

Chang, SM ;

O'Neill, AM ;

Friedman, AH ;

Bruner, J ;

Yue, N ;

Dugan, M ;

Zaknoen, S ;

Levin, VA .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2762-2771

[5]

2010, LANCET ONCOL, V11, P805

← 1 →